Data / Form D filings / MERITAGE PHARMA INC
MERITAGE PHARMA INC: Form D filings
MERITAGE PHARMA INC, a pharmaceuticals company in San Diego, CA, filed 3 Form D notices with the SEC between 2009 and 2011. The latest, on November 16, 2011, reports $6.5 million sold of a $7.5 million offering to 10 investors.
Find out what MERITAGE PHARMA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12481 HIGH BLUFF DRIVE, SUITE 160, San Diego, CA, 92130
- Phone
- (858) 436-1660
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1432016
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 16, 2011 | Amendment | $7,500,002 | $6,500,002 | $1,000,000 | 10 | Jan 18, 2011 | sec.gov |
| Jan 27, 2011 | New notice | $5,500,001 | $2,000,001 | $3,500,000 | 10 | Jan 18, 2011 | sec.gov |
| Aug 27, 2009 | Amendment | $29,972,053 | $29,972,053 | $0 | 23 | Aug 17, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James C. Blair, Ph.D. | Director | |
| Elaine M. Phillips, Ph.D. | Executive Officer, Director | |
| Cam L. Garner | Director | |
| Kenneth J. Widder, M.D. | Director | |
| Malcolm R. Hill | Executive Officer | |
| Adam K. Simpson | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Nov 14, 2011 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what MERITAGE PHARMA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.